SUMMARY A double-blind placebo-controlled study of minocycline in 221 men with nongonococcal urethritis (NGU) was undertaken. Techniques were used which enabled diagnoses of chlamydial and mycoplasmal infections to be made within 24 hours of a patient attending a clinic. All patients from whom Chlamydia trachomatis was isolated were treated with minocycline, while patients from whom Ureaplasma urealyticum or Mycoplasma hominis was isolated, or from whom no micro-organisms were isolated, were treated on a double-blind basis with either minocycline or placebo.
Introduction
In the last 30 years it has been demonstrated convincingly that non-gonococcal urethritis (NGU) responds better to tetracyclines and erythromycin than to penicillin derivatives or placebos,' 2 thus suggesting a microbial aetiology. Further studies have sought an organism or organisms responding to the same range of antimicrobial agents that are effective in treating the disease. While there is convincing evidence that Chlamydia trachomatis is involved,3 and some evidence for the role of Ureaplasma urealyticum,4 the extent to which these micro-organisms act as primary pathogens in acute and recurrent NGU is unclear.
We present the short-term results of a double-blind placebo-controlled study of minocycline in patients with NGU attending two West London clinics. By using cycloheximide-treated McCoy cells combined with indirect immunofluorescent antibody staining5 we were able to isolate chlamydia within 24 hours and so allot patients to particular treatment groups based on microbiological findings. In this way it was possible to focus attention on the chlamydia-negative patients in order to elucidate the role of mycoplasmas, in particular ureaplasmas, in the disease and to investigate the group of patients from whom micro-organisms were not isolated.
Patients and methods

SELECTION OF PATIENTS
Men attending two venereal disease clinics in West London during specified morning sessions were con-327 sidered for inclusion in the study if the following criteria were fulfilled: (1) a Gram-stained smear of urethral exudate or scraping contained 15 or more polymorphonuclear leucocytes per high-power microscope field (x 800 magnification) (PMNL/hpf) but no Gram-negative diplococci presumptively identified as N gonorrhoeae; (2) antibiotics had not been taken during the seven days before attendance; (3) the patient was prepared to reattend on at least three subsequent occasions; and (4) informed consent was given to participate in the study.
DESIGN OF THE STUDY
The study was approved by the ethics committees of the participating hospitals. Patients were informed that the purpose of the study was to identify possible causative organisms of NGU. Specimens were taken from patients at the first visit and they were asked to reattend the following day, when the results of tests would be available and appropriate treatment given.
Chlamydia-positive patients were treated with minocycline (Minocin, Lederle) 1 3 g in divided doses over a six-day period (a loading dose of 200 mg and twice daily doses of 100 mg thereafter) because we considered it to be unethical to withhold antibiotic treatment from patients infected with a microorganism widely believed to be a pathogen. Patients who were chlamydia-negative but mycoplasmapositive (either U urealyticum or M hominis) were treated on a double-blind basis with either minocycline or a placebo (lactose tablets). Patients wvho were isolation-negative were treated also on a doubleblind basis with either minocycline or placebo. Patients were instructed to complete the course of treatment, to abstain from alcohol and sexual intercourse, and to reattend one week later. Written instructions were issued.
At each follow-up visit clinical and microbiological assessments were undertaken and appropriate treatment prescribed for those patients who were not considered to be cured. Follow-up was continued until the patient was regarded as cured on the basis of tests on two consecutive visits at least one week apart. Those who admitted to sexual intercourse were not excluded so that it was possible to consider the role that reinfection might play in recurrent disease. Sexual partners were seen when possible and were treated empirically with tetracyclines.
MANAGEMENT AT FIRST ATTENDANCE A full medical history was taken. The genital area was examined and a smear made from the urethral exudate or, in the absence of exudate, from a scraping obtained from the anterior urethra with a bacteriological loop; the smear was Gram-stained and examined for PMNL and Gram-negative diplococci. A second specimen, taken similarly, was plated directly on to a non-selective medium consisting of GC agar base (Difco) containing 2Wo v/v Isovitalex (BBL), which was incubated at 37°C in 57o CO2 in air. After 24 hours the medium was examined for typical colonies of N gonorrhoeae. Suspicious colonies were subcultured and identified by Gram-staining and an oxidase test. Patients who were suspected or proved to have gonorrhoea were excluded from the study. An endourethral specimen was then taken for the isolation of C trachomatis as described.6 A second nasopharyngeal swab was inserted 3 cm into the urethra and expressed in mycoplasma standard liquid medium. Urine was also collected for the isolation of mycoplasmas.
The specimens were kept at room temperature until titration in urea-containing and argininecontaining media within five hours of collection. 7 Organisms producing a colour change in ureacontaining medium were regarded presumptively as U urealyticum and those which hydrolysed arginine as M hominis.
A specimen of blood was taken when possible for serological tests 
DIAGNOSIS OF CURE
For analysis a patient was regarded as cured if he was asymptomatic and had <15 PMNL/hpf in a urethral smear or scrape. These criteria differed from those used to determine the need for retreatment during the study when it was felt that clinical judgment must override defined research criteria. Cure rates were calculated from the proportion of all patients (excluding defaulters) who were known to be cured.
STATISTICAL METHODS
Groups were compared by x2 tests, using Yates's correction for 2 x 2 tables. The x2 test for trend was used to analyse variables with ordered categories.
Results
MICRO-ORGANISMS ISOLATED INITIALLY
The study group consisted of 241 patients, of whom 20 were excluded because they were shown to have gonorrhoea or because of technical problems in the isolation of chlamydia. Of the remaining 221 patients, C trachomatis was isolated from 77 (35%7o), ureaplasmas from 96 (43%), and M hominis from 29 (13%o). The proportion of patients cured by treatment with minocycline was unrelated to the number of inclusions produced by specimens when inoculated into McCoy cell monolayers or to the microbiological severity of infection with U urealyticum as measured in colour-changing units (ccu/ml) (table IV). The numbers of patients infected with M hominis were too small to draw any valid conclusions.
FACTORS AFFECTING DISEASE OUTCOME IN MINOCYCLINE-TREATED PATIENTS Age, marital state, time since the last treatment for NGU, the apparent incubation period, a history of casual sexual contact, and the nature and duration of symptoms were unrelated to the outcome of the disease. The cure rate (44%) for West Indians, however, was lower than that for all other groups (58-80'/o). While a larger proportion of homosexual/bisexual patients (68%) appeared to be cured in comparison with heterosexuals (54%), the number of patients was too small to draw any conclusions. When the study group was analysed in terms of the number of previous episodes of NGU there appeared to be a trend suggesting that the clinical outcome was worse with increasing numbers of episodes; the cure rate was 59% for patients with a first episode and 401o for those experiencing their fifth or subsequent episode. This trend was not, however, statistically signif'icant (x2 = 1 *3; P>0 2).
MICROBIOLOGICAL RESPONSE TO TREATMENT C trachomatis was isolated from only one of 68 initially C(I) + patients who were treated with minocycline and who returned for follow-up and was not isolated from any patient at the second or subsequent follow-up visit. The one patient who failed to respond to minocycline was retreated with a second course of the drug and had a complete clinical and microbiological recovery. Although the putative pathogen was eradicated from 99% of patients clinical cure was achieved in only 54%. C trachomatis was not isolated from any initially C(I) -patients (including those seropositive patients treated with placebo) at any follow-up visit.
U urealyticum was isolated from nine of 52 (17%) patients initially U + after treatment with minocycline. Two of these patients admitted the Willcox et al,'3 however, using the same regimen, claimed a failure rate at three months of only 10-4%. In a previous study,'2 in which the same regimen was used but with less strict criteria for cure, we obtained a 10-8% failure rate. (4) The criteria for cure are more stringent than those used previously. We included in our "failure" group patients who had continuing urethritis and also those with subjective complaints. Our insistence on a scraping of the anterior urethra in the absence of any expressible discharge and the frequent finding of asymptomatic urethritis suggests that it might have been overlooked in previous studies.' 12 13 14 The interpretation of subjective complaints in the absence of evidence of urethritis is controversial. It is widely believed that these symptoms are psychogenic. Many patients with such complaints and without sexual reexposure, however, return within hours or days with a frank urethritis suggesting that signs of the disease are intermittent. It would, therefore, be unrealistic to dismiss such complaints without repeated investigation and wrong to regard the patient as "cured". (5) A low default rate (12%) occurred. Asymptomatic patients who considered themselves cured were persuaded to reattend, and many were found to have residual urethritis. If 30% of the patients had defaulted and had been excluded, as usually occurs, it would have required only 56 of an initial 100 patients to reattend cured to achieve an 80% cure rate (that is 56/70). While we have complied with the usual method of determining the cure rate, an alternative approach is to express it as a ratio of the number of patients who reattend cured to the total number in the study (that is, 56/100 in the above example). Similarly, a failure rate (14/100) would comprise that proportion of the total number of patients who failed to respond to treatment. The cure rate, failure rate, and default rate would total 100%. In our study, these rates for minocyclinetreated patients would be 49%, 39%, and 12%. Of these five possibilities for a relatively poor response to treatment, we believe that the last two are the most likely.
Although chlamydial urethritis was not the principal focus of this study, one aspect is worthy of note. The clinical outcome for patients with chlamydial urethritis was found not to differ from that for those with non-chlamydial urethritis, which is in agreement with the finding of Oriel et al. 15 This is also in keeping with the short-term results of Handsfield et al, 16 although they reported that patients with non-chlamydial urethritis had a poorer long-term response to treatment. If chlamydial and non-chlamydial NGU respond in a similar way in both the short-term and long-term it seems unlikely that NGU is caused by a wide spectrum of different micro-organisms unless they act indirectly to trigger an underlying inflammatory process. An alternative proposition, that all cases of NGU are caused by chlamydia, is unlikely for reasons to be discussed.
The assessment of the role of U urealyticum in NGU is made more difficult by the poor clinical response of the C + patients. The fact that U + minocycline-treated patients responded equally as well as C + minocycline-treated patients suggests that ureaplasmas are playing a similar role to chlamydia in the pathological process. This view is strengthened by the response of U + placebo-treated patients to subsequent minocycline. As with chlamydial infections there was no evidence that the more severe infections, as assessed microbiologically, responded better or worse to treatment.
Ureaplasmas were reisolated from 14% of minocycline-treated patients and 81 "o of placebo-treated patients. The former must indicate treatment failure or reinfection and the latter spontaneous clearance of organisms in 19% of these patients. As the failure rate for U + minocycline-treated patients was greater than 14%o and the cure rate for placebo-treated patients greater than 197o, it is evident that the correlation between clearance of ureaplasmas and clinical cure was poor. This situation is similar, however, to that seen in chlamydial urethritis where clearance of the micro-organism was not always associated with clinical cure.
It should also be noted that cure rates were related to certain background factors which were also related to isolation of specific micro-organisms. For example, fewer West Indian patients were cured than Caucasians and mycoplasmas were isolated more frequently from West Indians than from Caucasians. Thus it might be argued that had West Indians not been overrepresented in the M+ groups, the cure rates for these groups might have been better. This is unlikely, however, since more than two-thirds of M + patients were C -and, as it is believed that Cpatients do worse than'6 or as well as'5 C + patients, it would be surprising if M + patients had a higher rate of cure than M -patients. Conversely, chlamydia were isolated less frequently from those patients who had been treated for NGU in the preceding three months although cure rates for these patients were almost identical to those for patients who had not been so treated. This again throws some doubt on the overriding importance of chlamydia as pathogens in NGU.
The clinical response to minocycline in the isolation-negative group 
